Natera, Inc. · NTRA · Next earnings

Natera, Inc. reports Thursday, Feb 25, 2027

NTRA reports after market close with consensus EPS at $0.01 and revenue at $749.5M. Last quarter: Natera raises 2026 revenue outlook as Signatera drives Q3 growth

Reports After market close111 days awayDate estimated Healthcare

What the street expects

Consensus for the coming report
Consensus EPS $0.01 Calendar consensus
Consensus revenue $749.5M Calendar consensus
Report date Feb 25, 2027 Thursday, date estimated
Session After market close 111 days away

Where NTRA left off: FY2026 Q3

Full report

Natera raises 2026 revenue outlook as Signatera drives Q3 growth

EPS surprise -49.3% Reported $-0.42 vs $-0.28
Revenue surprise +12.2% Reported $794.0M vs $707.5M
Stock move -15.2% Event window
Subsequent drift 0.0% Up to 20 sessions

Raised full-year 2026 revenue guidance to $3.05–$3.35 billion; management also set a $6 billion revenue target for 2029. The supplied prior-quarter analysis listed FY revenue guidance of $2.85–$2.91 billion.

What to watch on the call

Carried forward from the last transcript

Risks management flagged

  • The assumptions and sustainability behind the raised revenue outlook and $6 billion 2029 target remain key questions.
  • Operating expense is expected to increase in 2027, particularly for data and early-cancer detection investments; newer products may pressure gross-margin progression as they scale.
  • Revenue contribution depends in part on MolDX and other reimbursement decisions, Japan launch execution, and expected reimbursement levels.

Questions analysts left open

  • Sustainability of revenue guidance and assumptions behind the $6 billion target.
  • Magnitude and timing of 2027 operating-expense growth, especially for data and early-cancer detection.
  • Gross-margin trajectory as newer, lower-margin products scale, and timing and revenue impact of MolDX submissions.

Ask FN2 about NTRA next report

Choose a question to continue your research
What should I watch for in NTRA's next earnings report?How did NTRA guide last quarter, and is consensus above or below that?Give me the bull and bear case going into NTRA earnings.

Free to start. Your question opens in chat for you to review and send. FN2 can look up the transcript, financials and prior quarters.

Get the NTRA recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Recent NTRA quarters

All NTRA earnings
-15.2%FY2026 Q3

Sources

  1. FN2 corporate events calendar, resolved from the earnings calendar feed
  2. FN2 earnings calendar analyst consensus
  3. Earnings call transcript analysis, FY2026 Q3

Methodology

The report date comes from FN2's resolved corporate-events calendar and is marked estimated until the company confirms it. Consensus figures are the calendar's latest analyst estimates for the fiscal period and are not an FN2 forecast.

Risks and open questions are carried forward verbatim from FN2's structured analysis of the previous earnings call. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.